 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Kevin Deane and David Fox.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.308 |
|
|
|
-
Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2026 Apr; 78(4):809-820.
Score: 0.246
-
Inamo J, Bylinska A, Smith M, Vanderlinden L, Wright C, Stephens T, Feser ML, Striebich CC, O'Dell JR, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos AN, Fox DA, Danila MI, Horowitz DL, Kay J, James JA, Holers VM, Deane KD, Guthridge JM, Zhang F. Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion. medRxiv. 2026 Feb 17.
Score: 0.061
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|